Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) (PAR-20-101)

Sponsor: National Institutes of Health

Due Date: May 27, 2020; May 27, 2021; May 27, 2022

Harmonization of Alzheimers Disease and Related Dementias (AD/ADRD) Genetic, Epidemiologic, and Clinical Data to Enhance Therapeutic Target Discovery (U24 Clinical Trial Not Allowed) (PAR-20-099)

Sponsor: National Institute on Aging

Due Date: Standard dates apply. The first standard due date for this FOA is May 25, 2020

Accelerating Medicine Partnership in Parkinsons disease (AMP PD) data use and analysis (U01 Clinical trials not allowed) (RFA-NS-20-027)

Sponsor: National Institute of Neurological Disorders and Stroke

Award: The National Institute of Neurological Disorders and Stroke intends to commit $2.2 million in FY 2020 to fund four to 10 awards.

Due Date: March 18, 2020.

Limited Competition: National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD) (U24 Clinical Trial Not Allowed) (RFA-AG-21-005)

Sponsor: National Institute on Aging

Award: NIA intends to commit $6 million in FY 2021 to fund one award.

Due Date: June 17, 2020.

New/Unconventional Animal Models of Alzheimers Disease (R24 Clinical Trial Not Allowed) (RFA-AG-21-003)

Sponsor: National Institute on Aging

Award: NIA intends to commit a total of $5,250,000 in FY 2021 to fund four awards pending review and submission of sufficiently meritorious applications.

Due Date: October 7, 2020

Development of Research Education Resources for Geriatrics-Related Translational and Clinical Scientists (R25 Independent Clinical Trial Not Allowed) (PAR-20-095)

Sponsor: National Institute on Aging

Due Date: Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. The first standard application due date for this FOA is May 25, 2020.

Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards (NOT-OD-20-055)

Sponsor: National Institutes of Health

Notice of Special Interest: Alzheimers-focused administrative supplements for NIH/NIDDK grants that are not focused on Alzheimers disease (NOT-DK-20-009)

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases

NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional) (PAR-20-084)

Sponsor: National Institute of Biomedical Imaging and Bioengineering

Due Date: Standard dates apply.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) (PAR-20-038)

Sponsor: National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism

Due Date: Standard dates apply The first standard application due date for this FOA is February 5, 2020.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed) (PAR-20-037)

Sponsor: National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism

Due Date: Standard dates apply. The first standard application due date for this FOA is February 5, 2020

White Matter Lesion Etiology of Dementia in the U.S. Including in Health Disparity Populations (U19 Clinical Trial not Allowed) (RFA-NS-20-013)

Sponsor: National Institutes of Health

Award: NIH intends to commit $9.5 million total costs in FY 2020 to fund one award.

Due Date: March 31, 2020

BRAIN Initiative: Biology and Biophysics of Neural Stimulation and Recording Technologies (R01 Clinical Trials Optional) (RFA-NS-20-006)

Sponsor: National Institutes of Health

Award: NIH anticipates providing $10 million per year to fund an estimated 10 to 15 awards.

Due Date: March 24, 2020; June 2, 2020; October 1, 2020; February 2, 2021; June 1, 2021; October 1, 2021; February 1, 2022; June 1, 2022; and October 3, 2022 by 5 p.m. local time of applicant organization.

Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) (PAR-20-082)

Sponsor: National Institutes of Health

Due Date: Standard dates apply. The first standard due date for this FOA is February 16, 2020.

Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) (PAR-20-055)

Sponsor: National Institutes of Health

Due Date: Standard dates apply. The first standard due date for this FOA is February 5, 2020.